BioSpace News Archive

Protagonist Therapeutics, Inc., a clinical stage biopharmaceutical company, announced the pricing of its previously announced underwritten public offering of 4,761,904 shares of its common stock at a price to the public of $21.00 per share.

in June 2020, Tychan began its Phase 1 clinical safety trials in humans to evaluate TY027, a monoclonal antibody (mAb) that specifically targets SARS-CoV-2, the virus that causes COVID-19. In October 2020, approval from Health Sciences Authority of Singapore (HSA) was obtained for the Phase 3 clinical trial to begin as part of the progressi

The surgical patch is coated with coagulation factors such as human thrombin and human fibrinogen and is composed of an equine collagen sponge.

Respiration rate is measured as the number of breaths per minute. Respiration rate is normally calculated when the person is at rest and not involved in any physical activity and varies with medical conditions.

Oblato, Inc., a wholly owned U.S. subsidiary of the Korean biotech company GtreeBNT Co., Ltd., announced it had official discussions with the FDA on a detailed plan for a phase 1/2 clinical trial to start developing a new treatment for Diffuse Intrinsic Pontine Glioma, a rare pediatric disease, using its proprietary drug, OKN-007.

The systemic scleroderma treatment market is predicted to chart a notable growth trajectory over the forecast period from 2019 to 2029.

Transparency Market Research has published a new report titled, ‘Enteric Disease Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

Castrate-Resistant Prostate Cancer (CRPC) can be defined as a disease progression even after the administration of androgen depletion therapy.

As the number of COVID-19 cases continue to rise in the U.S., Russia, France, and Brazil, life-threatening and rare brain diseases are being linked to the infection.

Endoscopic mucosal resection and endoscopic submucosal dissection, are most common type of Endoscopic resection techniques, which is aided by injection of submucosal lifting agents to expand the submucosal area, untangles polypectomy and reduces the chances of adverse effects.